Inspired by previous whole-body hyperthermia studies, Verthermia has conducted research on how this new treatment works on a cellular level.
Since the 1980s, Verthermia® has studied and refined HEATT®. Blood flows into our circuit, gently heats, then returns to the body as we raise the patient's whole-body temperature to 42° Celsius (107.6°F) to destroy, damage, or slow the growth of cancer cells. During HEATT®, the patient is closely monitored to ensure safety throughout the procedure.
HEATT® provides whole-body hyperthermia cancer treatment through a perfusion based procedure that does not involve surgical resection of tumors or radiation.
At Verthermia®, we believe that everyone should have access to effective cancer treatments and strive to provide our clients with the best care possible. We are committed to continuing research on whole-body hyperthermia so that we can provide the latest information on its efficacy in treating cancer. Our team has conducted clinical trials, which to date have shown positive patient outcomes with whole-body hyperthermia treatment.
Our ovarian cancer trial resulted in significant findings on the positive impacts of HEATT®. Patients overall experienced improved survival rates and daily living satisfaction.
Verthermia® trial patients with unresponsive lung cancer exceeded average life expectancy after receiving HEATT®.
Our mission is to support our patients on their journey toward improved health and well-being. To this end, we provide a wealth of educational webinars, online resources, and panel discussions led by experts in hyperthermia therapy. In these sessions, you can learn more about the whole-body hyperthermia process including trial results, patient success stories, and more. We also provide our patients with in-depth information about the science and technology behind HEATT®.
At Verthermia®, we prioritize the safety and well-being of our patients above all else. We uphold stringent standards to ensure that every patient undergoing whole-body hyperthermia cancer treatment will do so in a manner that guarantees their safety and minimizes potential complications. To be eligible for HEATT®, a patient must meet certain requirements. Contact us today if you would like more information about your candidacy.
We understand that learning about the science of whole-body hyperthermia cancer treatment is important for cancer patients and their families. Here are some frequently asked questions that can help you make an informed and confident decision about HEATT®.
Hyperthermia cancer treatment is a promising approach in the field of oncology, offering potential benefits for patients suffering from advanced-stage […]Read More For Overview
The Verthermia® team conducted an FDA Phase 1 clinical trial during 2014-2015, resulting in significant findings on the positive impact […]Read More For Overview
The image on the left shows the tumors at the beginning of the study. The image on the right shows […]Read More For Overview